These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 17107236

  • 1. Cognitive and functional effects of atypical antipsychotic medications.
    Harvey PD.
    J Clin Psychiatry; 2006 Oct; 67(10):e13. PubMed ID: 17107236
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.
    Harvey PD, Keefe RS.
    Am J Psychiatry; 2001 Feb; 158(2):176-84. PubMed ID: 11156796
    [Abstract] [Full Text] [Related]

  • 6. Cognitive effects of conventional and atypical antipsychotics in schizophrenia.
    Sharma T.
    Br J Psychiatry Suppl; 1999 Feb; (38):44-51. PubMed ID: 10884899
    [No Abstract] [Full Text] [Related]

  • 7. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Heinrichs RW.
    Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.
    Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL.
    Am J Psychiatry; 2000 May; 157(5):767-71. PubMed ID: 10784470
    [Abstract] [Full Text] [Related]

  • 10. Important steps in the development of cognitive-enhancing drugs in schizophrenia.
    Buchanan RW.
    Am J Psychiatry; 2006 Nov; 163(11):1867-9. PubMed ID: 17074932
    [No Abstract] [Full Text] [Related]

  • 11. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998 Nov; 59 Suppl 12():35-40. PubMed ID: 9766618
    [Abstract] [Full Text] [Related]

  • 12. Cognitive effects and antipsychotic treatment.
    Kasper S, Resinger E.
    Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():27-38. PubMed ID: 12504070
    [Abstract] [Full Text] [Related]

  • 13. Improvement of cognitive dysfunction after treatment with second-generation antipsychotics.
    Weiss E, Kemmler G, Fleischhacker WW.
    Arch Gen Psychiatry; 2002 Jun; 59(6):572-3; author reply 573-5. PubMed ID: 12044210
    [No Abstract] [Full Text] [Related]

  • 14. Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.
    Velligan DI, Miller AL.
    J Clin Psychiatry; 1999 Jun; 60 Suppl 23():25-8. PubMed ID: 10625197
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact on cognition of the use of antipsychotics.
    Sharma T.
    Curr Med Res Opin; 2002 Jun; 18 Suppl 3():s13-7. PubMed ID: 12418607
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol.
    Sergi MJ, Green MF, Widmark C, Reist C, Erhart S, Braff DL, Kee KS, Marder SR, Mintz J.
    Am J Psychiatry; 2007 Oct; 164(10):1585-92. PubMed ID: 17898351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.